Medtronic plc
New York Stock Exchange•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Company Description
- CEO
- Mr. Geoffrey Straub Martha
- Full Time Employees
- 95,000
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 20 On Hatch Dublin Ireland 2
- IPO Date
- May 2, 1973
- CIK
- 0001613103
- Website
- medtronic.com
- Similar Companies
- Business
- Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Company News
Medtronic: Undervalued Dividend Aristocrat With High Margins
MDT Stock Trades Near 52-Week High: Is it a Smart Buy Now?
Buy 4 October Dividend Aristocrats & Watch 10
The Zacks Analyst Blog JPMorgan, Medtronic, Shopify and Perma-Pipe International
Medtronic (MDT) Advances But Underperforms Market: Key Facts
Medtronic voluntarily recalls insulin pumps due to risk of shortened battery life
Voluntary recall notifying Medtronic insulin pump users of potential risks of shortened pump battery life
Mexico Spinal Implants Market Size, Share & Trends Analysis 2024-2030, with Focus on Market Leaders ZimVie/Highridge Medical, Medtronic and DePuy Synthes
Reasons to Retain Medtronic Stock in Your Portfolio Now
GI Alliance Collaborates with Medtronic to Introduce GI Genius™ AI Technology for Enhanced Colon Polyp Detection
Positive Trial Outcome for PulseSelect PFA Likely to Boost MDT Stock
New clinical data demonstrate excellent lesion durability with PulseSelect™ Pulsed Field Ablation System in real-world setting as approvals and adoption expand globally
Why Medtronic (MDT) is a Top Value Stock for the Long-Term
My Best Dividend Aristocrats For October 2024
Federated Hermes, Inc. launches MDT Mid Cap Growth Collective Investment Fund
The Smartest Dividend Stocks to Buy With $10,000 Right Now
MDT Stock Might Gain From Expanded AiBLE Ecosystem and New Partnership
Medtronic expands AiBLE™ spine surgery ecosystem with new technologies and Siemens Healthineers partnership
Going Ex-Dividend
Medtronic (MDT) Up 0.7% Since Last Earnings Report: Can It Continue?